Exploring the Antiovarian Cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking
Computational and Mathematical Methods in Medicine · 29.11.2022 · 2022 · 1-12
DOI: 10.1155/2022/7895246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computational and Mathematical Methods in Medicine, erschienen am 29.11.2022. Verfasst von Xiao Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Salvia miltiorrhiza, Ovarian Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Ovarian cancer was one of the gynecological malignant tumors. Salvia miltiorrhiza Bunge (SMB) was a kind of herbal medicine with an antitumor effect. However, the inhibitory effect of SMB on ovarian cancer and its potential mechanism were still unclear.
Objective
The antitumor effect of SMB on ovarian cancer was studied by network pharmacology and molecular docking techniques, and its possible molecular mechanisms were analyzed.
Method
The active ingredients of SMB and the target data of ovarian cancer were obtained from the Traditional Chinese Medicines for Systems Pharmacology Database (TCMSP) and the GeneCards database. The relationship between active ingredients of SMB and ovarian cancer targets was analyzed by String database, David 6.8 online database, and Cytoscape 3.7.2 software, and then potential pathways were screened out. In addition, molecular docking technology was used to verify further the binding effect of antiovarian cancer pathway targets with active ingredients of SMB. Finally, survival analysis was performed for all potential targets.
Results
We analyzed 71 SMB–ovarian cancer common targets, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis showed that the PI3K-Akt signaling pathway might be an essential pathway for SMB to inhibit ovarian cancer. Luteolin, Tanshinone IIA, and Cryptotanshinone in SMB might play an important role. HSP90AA1, CDK2, and PIK3CG might be potential targets of SMB in inhibiting ovarian cancer.
Conclusion
Through network pharmacology and molecular docking analysis, we found that SMB might partially inhibit ovarian cancer by the PI3K-Akt signaling pathway. We believe that SMB might be a potential therapeutic agent for ovarian cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Dalian Medical University, Dalian, China.
- Division of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
- Medical Imaging Diagnosis Centre, General Hospital of Fushun Mining Bureau of Liaoning Health Industry Group, Fushun, China.
- Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Second Hospital of Dalian Medical University, Dalian, China.
ORCID-Profile: Xiao Xu, Zhiwei Zhang, Likun Liu, Cheng Che, Weiling Li
Förderung
- Natural Science Foundation of Liaoning Province
- National Natural Science Foundation of China
Zitieren
APA
Xu, X., Zhang, Z., Liu, L., Che, C., & Li, W. (2022). Exploring the Antiovarian Cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking. Computational and Mathematical Methods in Medicine, 2022, 1-12. https://doi.org/10.1155/2022/7895246
Vancouver
Xu X, Zhang Z, Liu L, Che C, Li W. Exploring the Antiovarian Cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking. Computational and Mathematical Methods in Medicine. 2022;2022:1-12. doi:10.1155/2022/7895246
BibTeX
@article{Xu2022,
author = {Xu, Xiao and Zhang, Zhiwei and Liu, Likun and Che, Cheng and Li, Weiling},
title = {Exploring the Antiovarian Cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking},
journal = {Computational and Mathematical Methods in Medicine},
year = {2022},
volume = {2022},
pages = {1--12},
doi = {10.1155/2022/7895246}
}
EUVIMED